该试验预计将于2022年启动,其结果将为TAEUS装置在中国用于NAFLD的潜在商业化提供临床证据。
ENDRA(NDRA)首席执行官弗朗索瓦·米其隆(Francois Michelon)表...查看全文
智通财经APP预告,2021年5月18日,港美股上市公司活动及香港重要财经会议信息情况如下: 04:30 ENDRA Life Sciences, Inc.(NDRA.US) ENDRA Life Sciences, Inc.(NDRA.US)2021年第一季度业绩电话会 网络转播 04:30 GAN Limited(GAN.US) G... 网页链接
$Endra Life Sciences(NDRA)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001654954-21-004807 Act: 34 Size: 49 KB 网页链接
$Endra Life Sciences(NDRA)$ 8-K Current report, items 2.02 and 8.01 Accession Number: 0001654954-21-004654 Act: 34 Size: 29 KB 网页链接
$Endra Life Sciences(NDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-025859 Size: 5 KB 网页链接
$Endra Life Sciences(NDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-025849 Size: 5 KB 网页链接
$Endra Life Sciences(NDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-025861 Size: 5 KB 网页链接
$Endra Life Sciences(NDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-025866 Size: 5 KB 网页链接
$Endra Life Sciences(NDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-025850 Size: 5 KB 网页链接
$Endra Life Sciences(NDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-025853 Size: 5 KB 网页链接
$Endra Life Sciences(NDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-025842 Size: 5 KB 网页链接
$Endra Life Sciences(NDRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-21-025846 Size: 9 KB 网页链接